Refractory Hematologic Malignancy
specificA hematologic malignancy that is resistant to treatment.
19
Centers
18
Active Trials
—
Cancer Funding
Top Centers for Refractory Hematologic Malignancy(19)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 53.8 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 53.8 |
| 3 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 53.8 |
| 4 | NCI Comprehensive Active Research Program | 53.8 |
| 5 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 53.8 |
| 6 | NCI Comprehensive Active Research Program | 53.8 |
| 7 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 53.8 |
| 8 | NCI Comprehensive Active Research Program | 53.8 |
| 9 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 53.8 |
| 10 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 53.8 |
| 11 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 53.8 |
| 12 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 53.8 |
| 13 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 53.8 |
| 14 | University of Illinois Cancer CenterChicago, IL Active Research Program | 53.8 |
| 15 | Boston University Cancer CenterBoston, MA Active Research Program | 53.8 |
| 16 | Cancer Center at IllinoisUrbana, IL Active Research Program | 53.8 |
| 17 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 53.8 |
| 18 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 53.8 |
| 19 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive | 31.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →